Summary
This technical report discusses the evolving landscape of drug delivery device development within the pharmaceutical industry. It outlines the challenges faced by pharmaceutical companies, including rising development costs and the need for innovative solutions to meet unmet medical needs. The report highlights the increasing importance of drug delivery systems and the strategic partnerships forming between pharmaceutical companies and drug delivery solution providers. It details the FDA's initiatives to enhance product safety and the shift towards common product platforms among original equipment manufacturers. The report also emphasizes the significance of ultra-low power performance and connectivity in consumer medical devices, such as insulin delivery systems and smart inhalers. Key technological advancements from providers like Freescale Semiconductor are presented, focusing on their contributions to low-power operation and connectivity standards, including USB and Bluetooth technologies. The report concludes by addressing the regulatory challenges impacting development timelines and costs in the medical device sector.
